Amgen Stock Slips Below Recent High Amid Broader Market Gains
Amgen stock closed lower than expected on September 18, 2026, underperforming the broader US market. The shares slipped by 1.6% to close at $385.65 on the Nasdaq, while the S&P 500 index rose modestly by 0.3%. Trading volume for Amgen reached approximately 2.8 million shares, in line with its recent average.
The stock's performance was relatively soft compared to the benchmark index, but it remains above a 52-week low of around $260 and below a recent high near $400. This positioning suggests that the stock is trading within the upper half of its 52-week range.
Market attention today centers on upcoming US economic data and central-bank related commentary, which could influence risk appetite for defensive healthcare stocks like Amgen. No company-specific earnings release is scheduled for Amgen today, so investors will likely watch sector moves and macro news for cues into today's trading.